Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1975;37:309-317

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watanabe, A. M.
Right arrow Articles by Besch, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watanabe, A. M.
Right arrow Articles by Besch, H. R., Jr

Circulation Research, Vol 37, 309-317, Copyright © 1975 by American Heart Association


ARTICLES

Interaction between cyclic adenosine monophosphate and cyclic gunaosine monophosphate in guinea pig ventricular myocardium

AM Watanabe and HR Besch Jr

The purpose of this study was to examine the mechanisms underlying adrenergic-cholinergic antagonism in ventricular myocardium. Myocardial contractility, cyclic adenosine monophosphate (AMP) levels, and cyclic guanosine monophosphate (GMP) levels were measure in isolated guinea pig ventricles after treatment with various inotropic agents given alone and simultaneously with acetylcholine. Acetylcholine alone markedly elevated cyclic GMP levels but did not substantially change myocardial contractility. However, the same concentration of acetylcholine significantly attenuated the inotropic effect of isoproterenol and histamine, two drugs that may act by increasing myocardial levels of cyclic AMP. The decrease in the inotropic response to isoproterenol did not appear to be due to a decrease in the generation of cyclic AMP, because cyclic AMP levels were similar in hearts receiving isoproterenol alone and those receiving isoproterenol with acetylcholine. Dibutyryl cyclic GMP also antagonized the intropic action of isoproterenol. Acetylcholine did not alter the inotropic effects of ouabain, an agent that increases myocardial contractility without changing cyclic AMP levels. These results suggest that cyclic GMP mediates the antiadrenergic effects of acetylcholine by specifically antagonizing the inotropic actions of cyclic AMP.


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
R. C Kukreja, R. Ockaili, F. Salloum, and L. Xi
Sildenafil-induced cardioprotection in rabbits
Cardiovasc Res, December 1, 2003; 60(3): 700 - 701.
[Full Text] [PDF]


Home page
CirculationHome page
E. Kodani, Y.-T. Xuan, H. Takano, K. Shinmura, X.-L. Tang, and R. Bolli
Role of Cyclic Guanosine Monophosphate in Late Preconditioning in Conscious Rabbits
Circulation, June 25, 2002; 105(25): 3046 - 3052.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J.-B. Shen and A. J. Pappano
On the Role of Phosphatase in Regulation of Cardiac L-Type Calcium Current by Cyclic GMP
J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 501 - 506.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. J. Crystal, X. Zhou, S. Alam, A. Piotrowski, and G. Hu
Lack of role for nitric oxide in cholinergic modulation of myocardial contractility in vivo
Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H198 - H206.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Shinmura, X.-L. Tang, H. Takano, M. Hill, and R. Bolli
Nitric oxide donors attenuate myocardial stunning in conscious rabbits
Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2495 - H2503.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J.-L. Balligand
Regulation of cardiac {beta}-adrenergic response by nitric oxide
Cardiovasc Res, August 15, 1999; 43(3): 607 - 620.
[Full Text] [PDF]


Home page
Circ. Res.Home page
M. G. Vila-Petroff, A. Younes, J. Egan, E. G. Lakatta, and S. J. Sollott
Activation of Distinct cAMP-Dependent and cGMP-Dependent Pathways by Nitric Oxide in Cardiac Myocytes
Circ. Res., May 14, 1999; 84(9): 1020 - 1031.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Takano, S. Manchikalapudi, X.-L. Tang, Y. Qiu, A. Rizvi, A. K. Jadoon, Q. Zhang, and R. Bolli
Nitric Oxide Synthase Is the Mediator of Late Preconditioning Against Myocardial Infarction in Conscious Rabbits
Circulation, August 4, 1998; 98(5): 441 - 449.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Bolli, S. Manchikalapudi, X.-L. Tang, H. Takano, Y. Qiu, Y. Guo, Q. Zhang, and A. K. Jadoon
The Protective Effect of Late Preconditioning Against Myocardial Stunning in Conscious Rabbits Is Mediated by Nitric Oxide Synthase : Evidence That Nitric Oxide Acts Both as a Trigger and as a Mediator of the Late Phase of Ischemic Preconditioning
Circ. Res., December 19, 1997; 81(6): 1094 - 1107.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
S. Hirono, M. O. Islam, M. Nakazawa, Y. Yoshida, M. Kodama, A. Shibata, T. Izumi, and S. Imai
Expression of Inducible Nitric Oxide Synthase in Rat Experimental Autoimmune Myocarditis With Special Reference to Changes in Cardiac Hemodynamics
Circ. Res., January 1, 1997; 80(1): 11 - 20.
[Abstract] [Full Text]


Home page
CirculationHome page
P. Mohan, D. L. Brutsaert, W. J. Paulus, and S. U. Sys
Myocardial Contractile Response to Nitric Oxide and cGMP
Circulation, March 15, 1996; 93(6): 1223 - 1229.
[Abstract] [Full Text]